US36266G1076
© BusinessWire
30.11.2025
GEHC
LISTED
NASDAQ
GE HealthCare builds on a century of innovation to shape the future of radiology at RSNA 2025
News Preview
At this year’s Radiological Society of North America’s (RSNA) 2025 Annual Meeting, GE HealthCare (Nasdaq: GEHC) will showcase a wave of significant innovations grounded by its legacy and deep, global commitment to advancing precision care. For more than a century, GE HealthCare has stood at the intersection of medicine and technology—helping clini...
Themefolio
Profiler
Peergroup
© BusinessWire
30.11.2025
GEHC
LISTED
NASDAQ
GE HealthCare unveils next-generation SIGNA MRI technology, aiming to boost efficiency, enhance patient experience, and advance sustainability
News Preview
GE HealthCare (Nasdaq: GEHC) today announced the 510(k) submissions to the U.S. Food and Drug Administration (FDA) seeking clearance for next-generation SIGNA™ MRI technology. Unveiled at the Radiological Society of North America’s 2025 Annual Meeting, these differentiated solutions are part of a wave of new GE HealthCare innovations aimed at tack...
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2025
GEHC
LISTED
NASDAQ
GE HealthCare unveils Pristina Recon DL for mammography – deep learning image reconstruction technology delivering clearer image quality
News Preview
GE HealthCare (Nasdaq: GEHC) announced today that it has received FDA Premarket Authorization for Pristina Recon DL, an advanced 3D mammography image reconstruction technology. Powered by deep learning, Pristina Recon DL sets a new standard in image definition and sharpness.
Breast cancer remains one of the most common cancers among women, with o...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
25.11.2025
GEHC
LISTED
NASDAQ
GE HealthCare introduces Genesis™ Radiology Workspace: a cloud-first solution with a goal for smarter, faster diagnosis
News Preview
GE HealthCare (Nasdaq: GEHC) announced the introduction of Genesis™ Radiology Workspace, a next-generation solution designed to transform radiology workflows, unify the user experience, and empower radiologists with great efficiency and precision. At the center of this innovation is Genesis™ View, 510(k) pending2, a powerful new viewer designed to...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
24.11.2025
GEHC
LISTED
NASDAQ
GE HealthCare announces cash dividend for fourth quarter of 2025
News Preview
The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the fourth quarter of 2025 payable on February 13, 2026, to all shareholders of record as of January 9, 2026.
About GE HealthCare Technologies Inc.
GE HealthCare is a trusted partner and leading global he...
Themefolio
Profiler
Peergroup
© BusinessWire
24.11.2025
GEHC
LISTED
NASDAQ
GE HealthCare’s Photonova™ Spectra with Deep Silicon reimagines photon-counting CT to see more, know more and achieve more
News Preview
GE HealthCare today announced the submission of a 510(k) to the U.S. FDA seeking clearance for Photonova™ Spectra,i its new photon-counting computed tomography (PCCT) system with advanced AI algorithmsii – marking a major milestone in the company’s decades-long history of CT innovation. Built on GE HealthCare’s proprietary Deep Silicon detector te...
Themefolio
Profiler
Peergroup
© BusinessWire
20.11.2025
GEHC
LISTED
NASDAQ
GE HealthCare to acquire Intelerad, advancing cloud-enabled enterprise imaging across care settings
News Preview
GE HealthCare (Nasdaq: GEHC) announced it has entered into an agreement to acquire Intelerad, a leading medical imaging software provider for the healthcare industry, for a purchase price of $2.3 billion paid in cash. This acquisition demonstrates GE HealthCare’s continued commitment to cloud-enabled and AI-powered solutions across care settings a...
Themefolio
Profiler
Peergroup
© BusinessWire
17.11.2025
GEHC
LISTED
NASDAQ
GE HealthCare announces Flyrcado milestone: Strong pilot results drive broader rollout at CVAUSA
News Preview
GE HealthCare (Nasdaq: GEHC) today announced that Cardiovascular Associates of America (CVAUSA), the largest network of private cardiology groups in the U.S., plans to broaden its adoption of GE HealthCare’s FDA-approved cardiac positron emission tomography (PET) radiotracer Flyrcado™ (flurpiridaz F 18) injection, across approximately 25 sites fol...
Themefolio
Profiler
Peergroup
© BusinessWire
16.11.2025
GEHC
LISTED
NASDAQ
GE HealthCare management to present at upcoming investor conference
News Preview
GE HealthCare (Nasdaq: GEHC) management will present at the following upcoming investor conference.
Jefferies Global Healthcare Conference in London, England – Tuesday, November 18, 2025 at 9:30 am GMT/4:30 am ET/3:30 am CT
GE HealthCare’s CFO, Jay Saccaro, will discuss a variety of topics related to business strategy and growth opportunitie...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
GEHC
LISTED
NASDAQ
GE HealthCare management to present at upcoming investor conference
News Preview
GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conference.
Jefferies Global Healthcare Conference in London, England – Tuesday, November 18, 2025 at 9:30 am GMT/4:30 am ET/3:30 am CT
A webcast of this event can be accessed at the GE HealthCare website: https://in...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
GEHC
LISTED
NASDAQ
GE HealthCare reports third quarter 2025 financial results
News Preview
GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2025.
GE HealthCare President and CEO Peter Arduini said, “We delivered robust orders with growth across all segments in the third quarter. This was led by customer demand for our differentiated solutions and a healthy capital equipment enviro...
Themefolio
Profiler
Peergroup
© BusinessWire
21.10.2025
GEHC
LISTED
NASDAQ
Carevance platform expands access to GE HealthCare’s clinical excellence with advanced patient monitoring and new perioperative hypotension management capability
News Preview
GE HealthCare (Nasdaq: GEHC) today announced it has received CE mark for its Carevance™ patient monitor, advancing accessible and reliable care for more customers starting in Europe. Built on GE HealthCare’s clinical excellence, Carevance offers a clinically reliable and cost-effective solution with validated parameters and an intuitive, efficient...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
20.10.2025
GEHC
LISTED
NASDAQ
GE HealthCare collaborates with two major medical systems to advance AI technology designed to transform hospital operations and improve patient care
News Preview
GE HealthCare (Nasdaq: GEHC) today announced collaborations with two leading U.S. health systems—The Queen’s Health Systems in Honolulu, HI and Duke Health in Durham, NC—to help advance the development of GE HealthCare’s new AI-driven hospital operations software. Both health systems plan to contribute their frontline expertise to inform GE Health...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
GEHC
LISTED
NASDAQ
GE HealthCare launches CareIntellect for Perinatal, a cloud-first application to optimize care delivery and help send families home healthy
News Preview
GE HealthCare (Nasdaq: GEHC) today announced the launch of CareIntellect™ for Perinatal2, a cloud-first Software-as-a-Service (SaaS) application designed to deliver clear, actionable insights that help clinicians improve maternal and fetal care.3 CareIntellect for Perinatal supports clinicians by integrating information from disparate clinical sou...
Themefolio
Profiler
Peergroup
© BusinessWire
13.10.2025
GEHC
LISTED
NASDAQ
University of Michigan study presentation at ANESTHESIOLOGY 2025 supports clinical and environmental benefits of End-tidal Control
News Preview
GE HealthCare (Nasdaq: GEHC) today announced the presentation of findings from the largest real-world evidence study to-date on End-tidal Control anesthesia delivery* software conducted at the University of Michigan. The results demonstrated the environmental and clinical benefits of End-tidal Control software and were presented at ANESTHESIOLOGY®...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
GEHC
LISTED
NASDAQ
GE HealthCare unveils Carestation 850 at ANESTHESIOLOGY 2025: its next-generation anesthesia delivery system designed to adapt to care needs
News Preview
GE HealthCare (Nasdaq: GEHC) today announced the unveiling of Carestation™ 850, its next-generation, FDA 510(k) pendingi anesthesia delivery system that is designed to help care teams adapt to evolving clinical and operational needs. Marking the latest evolution of GE HealthCare’s Carestation portfolio, Carestation 850 has the potential to advance...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
GEHC
LISTED
NASDAQ
GE HealthCare to announce third quarter 2025 results on October 29, 2025
News Preview
GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2025 financial results before the market opens on Wednesday, October 29, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://invest...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
GEHC
LISTED
NASDAQ
GE HealthCare debuts AI-supported solution, designed to improve and shorten the radiation therapy workflow, at ASTRO 2025
News Preview
GE HealthCare (Nasdaq: GEHC) today announced updates to Intelligent Radiation Therapy (iRT), a new version of the company’s software solution for radiation therapy workflow management, designed to reduce the time it takes for patients to go from diagnosis to treatment. The iRT solution is AI-supported by GE HealthCare and third-party applications,...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
GEHC
LISTED
NASDAQ
GE HealthCare announces cash dividend for third quarter of 2025
News Preview
The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the third quarter of 2025 payable on November 14, 2025 to all shareholders of record as of October 24, 2025.
About GE HealthCare Technologies Inc.
GE HealthCare is a trusted partner and leading global...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
GEHC
LISTED
NASDAQ
GE HealthCare announces intent to acquire icometrix to strengthen neurology portfolio with brain MRI assessment solutions
News Preview
GE HealthCare (Nasdaq: GEHC) today announced it has entered into an agreement to acquire icometrix, a company focused on providing AI-powered brain imaging analysis for neurological disorders such as Alzheimer’s disease to meet the growing demand for MRI in personalized treatment planning.
To complement its MR-guided AI-assisted scanning experti...
Themefolio
Profiler
Peergroup
© BusinessWire
08.09.2025
GEHC
LISTED
NASDAQ
GE HealthCare Enters an Agreement to Distribute Flyrcado Through CDL Nuclear Technologies Group, a Leading Provider of Cardiac PET Imaging Equipment and Services in the U.S.
News Preview
GE HealthCare (Nasdaq: GEHC) today announced a Distribution and Services Agreement (DSA) with CardioNavix, a part of the CDL Nuclear Technologies services group that provides end-to-end cardiac positron emission tomography (PET) imaging solutions to hospitals and outpatient practices throughout the U.S. Through this agreement, GE HealthCare aims t...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2025
GEHC
LISTED
NASDAQ
GE HealthCare unveils Vivid Pioneer, its most advanced AI-powered cardiovascular ultrasound system, designed to enhance speed and image quality for improved diagnostic confidence and workflow efficiency
News Preview
GE HealthCare (Nasdaq: GEHC) today announced the launch of the Vivid™ Pioneer, its most advanced, ultra-premium and adaptive cardiovascular ultrasound system yet, completely redesigned to support clinicians with extraordinary imaging in 2D, 4D and color flow, streamlined workflow, and enhanced diagnostic confidence. The ultrasound system recently...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
GEHC
LISTED
NASDAQ
GE HealthCare showcases integrated cardiology care pathway solutions and new AI-driven innovations at ESC 2025
News Preview
Today, leading up to the European Society of Cardiology (ESC) Congress 2025, GE HealthCare (Nasdaq: GEHC) introduced its latest suite of cardiology innovations designed to enhance clinical decision-making, improve workflow efficiency, and support earlier diagnosis and treatment of cardiovascular disease (CVD)—the world’s leading cause of death, re...
Themefolio
Profiler
Peergroup
© BusinessWire
21.08.2025
GEHC
LISTED
NASDAQ
GE HealthCare management to present at upcoming investor conferences
News Preview
GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences.
2025 Wells Fargo Healthcare Conference – Thursday, September 4, 2025 at 8:45 am ET/7:45 am CT
Morgan Stanley 23rd Annual Global Healthcare Conference – Tuesday, September 9, 2025 at 9:15 am ET/8:15 am CT...
Themefolio
Profiler
Peergroup
© BusinessWire
30.07.2025
GEHC
LISTED
NASDAQ
GE HealthCare reports second quarter 2025 financial results
News Preview
GE HealthCare (Nasdaq: GEHC) today reported financial results for the second quarter ended June 30, 2025.
GE HealthCare President and CEO Peter Arduini said, “We were pleased with solid orders and revenue performance in the second quarter across all segments, reflecting healthy customer investment in capital equipment. We also reported strong ea...
Themefolio
Profiler
Peergroup
© BusinessWire
24.07.2025
GEHC
LISTED
NASDAQ
GE HealthCare launches new advanced digital X-ray system to enable access and increase efficiency in high throughput settings
News Preview
GE HealthCare (Nasdaq: GEHC), today announced commercial availability of an advanced floor-mounted digital X-ray system, Definium™ Pace Select ET1, designed to deliver high-image quality and optimize efficiency in highly demanding environments while enhancing access and affordability.
X-ray exams often serve as the entry point to diagnostic imag...
Themefolio
Profiler
Peergroup
© BusinessWire
23.07.2025
GEHC
LISTED
NASDAQ
GE HealthCare drives growth with investment in AI-enabled medical devices and tops FDA’s list of AI authorizations for 4th Year with 100
News Preview
GE HealthCare (Nasdaq: GEHC) has topped a U.S. Food and Drug Administration (FDA) list of AI-enabled medical device authorizations for the fourth year in a row with 100 listed authorizations to date in the U.S.
This milestone reflects GE HealthCare’s continued research and development (R&D) investment and focus on developing AI solutions to...
Themefolio
Profiler
Peergroup
© BusinessWire
07.07.2025
GEHC
LISTED
NASDAQ
GE HealthCare to announce second quarter 2025 results on July 30, 2025
News Preview
GE HealthCare (Nasdaq: GEHC) will announce its second quarter 2025 financial results before the market opens on Wednesday, July 30, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor...
Themefolio
Profiler
Peergroup
© BusinessWire
01.07.2025
GEHC
LISTED
NASDAQ
GE HealthCare announces cash dividend for second quarter of 2025
News Preview
The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2025 payable on August 15, 2025 to all shareholders of record as of July 25, 2025.
About GE HealthCare Technologies Inc.
GE HealthCare is a trusted partner and leading global heal...
Themefolio
Profiler
Peergroup
© BusinessWire
24.06.2025
GEHC
LISTED
NASDAQ
FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients
News Preview
GE HealthCare (Nasdaq: GEHC) today announced that the U.S. Food and Drug Administration (FDA) has approved an updated label for its positron emission tomography (PET) imaging agent VizamylTM (flutemetamol F 18 injection) for beta-amyloid detection. The revised label, effective immediately, expands the indications for use, enables quantitative anal...
Themefolio
Profiler
Peergroup
© BusinessWire
23.06.2025
GEHC
LISTED
NASDAQ
GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025
News Preview
GE HealthCare’s commitment to advancing precision care in cardiology through innovative molecular imaging solutions is on full display at this week’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in New Orleans, Louisiana.
As cardiovascular disease (CVD) continues to rise globally,i the need for advanced diagnostic tec...
Themefolio
Profiler
Peergroup
© BusinessWire
21.06.2025
GEHC
LISTED
NASDAQ
GE HealthCare drives innovation in theranostics with latest technological advances
News Preview
At this year’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare is spotlighting the future of precision care with its innovative portfolio of theranostics-enabling solutions designed to help drive clinical and operational excellence. Making its debut, GE HealthCare’s MIM Software introduces LesionID Pro with...
Themefolio
Profiler
Peergroup
© BusinessWire
19.06.2025
GEHC
LISTED
NASDAQ
Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine
News Preview
Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration with Stanford Medicine – with one of their key intentions being the development and research of innovative total body PET/CT technology.i This effort is expected to explore new clinical pathways and help enhance patient outcomes thr...
Themefolio
Profiler
Peergroup
© BusinessWire
12.06.2025
GEHC
LISTED
NASDAQ
GE HealthCare advances precision care with MIM Encore™ to deliver next-generation digital imaging and workflow solutions
News Preview
GE HealthCare (Nasdaq: GEHC) proudly announces the combination of GE HealthCare’s proprietary features and algorithms with MIM Encore, marking a significant milestone in its mission to deliver precision care through advanced digital solutions. This implementation brings powerful new features to healthcare organizations boasting GE HealthCare syste...
Themefolio
Profiler
Peergroup
© BusinessWire
30.05.2025
GEHC
LISTED
NASDAQ
Updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Recommend Use of FES PET Imaging for Lobular Breast Cancer
News Preview
GE HealthCare (Nasdaq: GEHC) today announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for clinicians now recommend considering fluoroestradiol (FES) positron emission tomography (PET) for systemic staging in patients with recurrent or metastatic lobular breast cancer. GE HealthCare’s Cerianna™ (fluoroestradiol F18)...
Themefolio
Profiler
Peergroup
© BusinessWire
15.05.2025
GEHC
LISTED
NASDAQ
GE HealthCare launches CleaRecon DL, introducing AI-based 3D reconstruction to the interventional suite
News Preview
GE HealthCare (Nasdaq: GEHC) today announced the launch of CleaRecon DL, technology powered by a deep-learning algorithm, to improve the quality of cone-beam computed tomography (CBCT) images. This artificial intelligence (AI)-driven solution is designed to remove streak artifacts caused by the pulsatile nature of blood flow in the arteries and ch...
Themefolio
Profiler
Peergroup
© BusinessWire
13.05.2025
GEHC
LISTED
NASDAQ
GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent
News Preview
GE HealthCare (Nasdaq: GEHC) today announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for the company’s Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) ultrasound enhancing agent (UEA). This approval will help improve the clarity and diagnostic accuracy of echocardiograms in pedia...
Themefolio
Profiler
Peergroup
© BusinessWire
13.05.2025
GEHC
LISTED
NASDAQ
GE HealthCare and Raydiant Oximetry accelerate innovation in fetal oxygen saturation technology
News Preview
GE HealthCare (Nasdaq: GEHC) and Raydiant Oximetry, Inc. today announced a joint development initiative to enhance fetal monitoring capabilities that could strengthen the support of clinical decision-making during labor. This effort leverages the combined expertise and technology of the two companies to advance fetal oxygen saturation monitoring t...
Themefolio
Profiler
Peergroup
© BusinessWire
12.05.2025
GEHC
LISTED
NASDAQ
GE HealthCare unveils ultra-premium, high-performance gradient 1.5T MRI system
News Preview
GE HealthCare (Nasdaq: GEHC) today unveiled SIGNA™ Sprint, an FDA 510(k) pending1 ultra-premium wide bore 1.5T high-performance gradient MRI system, at the International Society for Magnetic Resonance in Medicine (ISMRM) 2025. This innovative technology is designed to unlock advanced imaging possibilities in cardiology, oncology and other clinical...
Themefolio
Profiler
Peergroup
© PR Newswire
05.05.2025
GEHC
LISTED
NASDAQ
AI Healthcare Boom Gains Speed as Regulators and Innovators Align
News Preview
Equity Insider News Commentary
Issued on behalf of Avant Technologies Inc.
VANCOUVER, BC, May 5, 2025 /PRNewswire/ --The integration of artificial intelligence (AI) into healthcare is here to stay, and adoption is accelerating. According to research from PYMNTS Intelligence which polled C-suite executives at healthcare companies generating at lea...
Themefolio
Profiler
Peergroup
© PR Newswire
05.05.2025
GEHC
LISTED
NASDAQ
AI Healthcare Boom Gains Speed as Regulators and Innovators Align
News Preview
Equity Insider News Commentary
Issued on behalf of Avant Technologies Inc.
VANCOUVER, BC, May 5, 2025 /PRNewswire/ --The integration of artificial intelligence (AI) into healthcare is here to stay, and adoption is accelerating. According to research from PYMNTS Intelligence which polled C-suite executives at healthcare companies generating at lea...
Themefolio
Profiler
Peergroup
© PR Newswire
05.05.2025
GEHC
LISTED
NASDAQ
AI Healthcare Boom Gains Speed as Regulators and Innovators Align
News Preview
Equity Insider News Commentary
Issued on behalf of Avant Technologies Inc.
VANCOUVER, BC, May 5, 2025 /CNW/ --The integration of artificial intelligence (AI) into healthcare is here to stay, and adoption is accelerating. According to research from PYMNTS Intelligence which polled C-suite executives at healthcare companies generating at least $1 b...
Themefolio
Profiler
Peergroup
© BusinessWire
02.05.2025
GEHC
LISTED
NASDAQ
ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions
News Preview
GE HealthCare (Nasdaq: GEHC) today announced an intended expansion of its radiation oncology portfolio as well as the introduction of the new AI-enabled MR Contour DL™ at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, Austria. The company will also showcase its updated Intelligent Radiation Therapy (iR...
Themefolio
Profiler
Peergroup
© BusinessWire
30.04.2025
GEHC
LISTED
NASDAQ
GE HealthCare reports first quarter 2025 financial results
News Preview
GE HealthCare (Nasdaq: GEHC) today reported financial results for the first quarter ended March 31, 2025.
GE HealthCare President and CEO Peter Arduini said, “First quarter results reflect strong execution as we start the year with robust revenue, orders and profit growth, which were driven by strength in the U.S. We remain focused on delivering...
Themefolio
Profiler
Peergroup
© BusinessWire
28.04.2025
GEHC
LISTED
NASDAQ
GE HealthCare management to present at upcoming investor conferences
News Preview
GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences.
Bank of America Securities Healthcare Conference in Las Vegas, NV – May 13, 2025 at 10:00 am CT / 11:00 am ET
Goldman Sachs 46th Annual Global Healthcare Conference in Miami, FL – June 10, 2025 at 9:00 am...
Themefolio
Profiler
Peergroup
© BusinessWire
24.04.2025
GEHC
LISTED
NASDAQ
GE HealthCare to feature latest advancements in diagnostic accuracy and patient-centered breast care at SBI 2025 Breast Cancer Imaging Symposium
News Preview
GE HealthCare (Nasdaq: GEHC), a global leader in breast health technology, will feature its latest advancements in diagnostic accuracy and patient-centered breast care during the 2025 Society of Breast Imaging Symposium in Colorado Springs, Co., April 24-27, 2025. This year’s showcase will feature new innovations designed to improve breast cancer...
Themefolio
Profiler
Peergroup
© BusinessWire
17.04.2025
GEHC
LISTED
NASDAQ
GE HealthCare to announce first quarter 2025 results on April 30, 2025
News Preview
GE HealthCare (Nasdaq: GEHC) will announce its first quarter 2025 financial results before the market opens on Wednesday, April 30, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor...
Themefolio
Profiler
Peergroup
© BusinessWire
10.04.2025
GEHC
LISTED
NASDAQ
Cincinnati Children’s and GE HealthCare build collaborative research program to drive pediatric imaging innovation
News Preview
Cincinnati Children’s and GE HealthCare (Nasdaq: GEHC) will form a strategic research program focused on driving clinical and technical research to advance innovation for pediatric care delivery across modalities, including magnetic resonance imaging (MRI), ultrasound, molecular imaging (MI), and computed tomography (CT). The research program will...
Themefolio
Profiler
Peergroup
© BusinessWire
09.04.2025
GEHC
LISTED
NASDAQ
GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions
News Preview
GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, announced the appointment of Jeannette Bankes as president and CEO, Patient Care Solutions, effective May 1, 2025.
Peter Arduini, president and CEO, GE HealthCare, said, “Jeannette is a proven leader who has diverse and deep experience at publicly traded companies in th...
Themefolio
Profiler
Peergroup
© BusinessWire
31.03.2025
GEHC
LISTED
NASDAQ
GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan
News Preview
GE HealthCare Technologies Inc. (GE HealthCare or the Company) (Nasdaq: GEHC) has completed its acquisition of the remaining 50% stake in Nihon Medi-Physics Co., Ltd (NMP), from Sumitomo Chemical, giving it full ownership. As part of GE HealthCare, NMP can further build on its expertise in developing and manufacturing proprietary and in-licensed r...
Themefolio
Profiler
Peergroup
© BusinessWire
28.03.2025
GEHC
LISTED
NASDAQ
GE HealthCare unveils Revolution™ Vibe CT system with Unlimited One-Beat Cardiac imaging and AI Solutions
News Preview
At the American College of Cardiology 2025 meeting, GE HealthCare (Nasdaq: GEHC) will proudly introduce Revolution™ Vibe,i a new computed tomography (CT) system with Unlimited One-Beat Cardiac imaging to deliver consistent, high-quality images for patients, even in challenging cases like atrial fibrillation and heavily calcified coronaries. Combin...
Themefolio
Profiler
Peergroup
© BusinessWire
27.03.2025
GEHC
LISTED
NASDAQ
GE HealthCare announces cash dividend for first quarter of 2025
News Preview
The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2025 payable on May 15, 2025 to all shareholders of record as of April 25, 2025.
About GE HealthCare Technologies Inc.
GE HealthCare is a trusted partner and leading global healthcar...
Themefolio
Profiler
Peergroup
© BusinessWire
27.03.2025
GEHC
LISTED
NASDAQ
ACC 2025: GE HealthCare announces the U.S. launch of pivotal innovations that will help transform the cardiology care pathway
News Preview
GE HealthCare (Nasdaq: GEHC) today announced the U.S. launch of Flyrcado™ (flurpiridaz F 18) injection at the 2025 American College of Cardiology (ACC) Annual Scientific Session & Expo, taking place March 29-31 in Chicago. Additionally, the company will showcase new AI-powered innovations, reflecting its strategy to leverage AI to help increas...
Themefolio
Profiler
Peergroup
© BusinessWire
20.03.2025
GEHC
LISTED
NASDAQ
GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premium to accelerate scanning and drive early cancer detection in dense breasts
News Preview
GE HealthCare (Nasdaq: GEHC) announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound offering advanced artificial intelligence (AI) and innovative features to drive faster*, reproducible supplemental screening and streamline exam readings on patients with dense breasts.
Approximately 71% of cancers oc...
Themefolio
Profiler
Peergroup
© BusinessWire
18.03.2025
GEHC
LISTED
NASDAQ
GE HealthCare and NVIDIA reimagine diagnostic imaging with autonomous X-ray and ultrasound solutions
News Preview
GE HealthCare (Nasdaq: GEHC) today announced a collaboration with NVIDIA at GTC 2025, expanding the existing relationship between the two companies to focus on pioneering innovation in autonomous imaging, beginning with autonomous X-ray technologies and autonomous applications within ultrasound.
GE HealthCare has been at the forefront of medical...
Themefolio
Profiler
Peergroup
© BusinessWire
17.03.2025
GEHC
LISTED
NASDAQ
GE HealthCare expands invasive cardiology solutions portfolio with AltiX AI.i for elevated experience in catheterization lab and electrophysiology procedures
News Preview
GE HealthCare (Nasdaq: GEHC) today announced the launch of the AltiX AI.i edition of Mac-Lab™, CardioLab™ and ComboLab™. The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offe...
Themefolio
Profiler
Peergroup
© BusinessWire
04.03.2025
GEHC
LISTED
NASDAQ
GE HealthCare Advances Its Cloud Strategy by Unveiling the Genesis Portfolio to Improve Speed of Digital Innovation Adoption
News Preview
GE HealthCare (Nasdaq: GEHC) today announced its new Genesis solutions, a portfolio of cloud enterprise imaging software-as-a-service (SaaS) solutions. Four features will be offered when commercially released – edge, storage, vendor neutral archive and data migration.i These cloud solutions, are designed to help enhance healthcare organizations’ e...
Themefolio
Profiler
Peergroup
© BusinessWire
27.02.2025
GEHC
LISTED
NASDAQ
GE HealthCare names new president and CEO, China
News Preview
GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, today announced that Yihao Zhang, president and CEO, China, will retire from the company effective July 1, 2025. Will Song, a Johnson & Johnson veteran for over 20 years, has been named GE HealthCare’s new president and CEO, China, and will join the company on April...
Themefolio
Profiler
Peergroup
© BusinessWire
26.02.2025
GEHC
LISTED
NASDAQ
GE HealthCare unveils Freelium, a next-generation sealed magnet platform at ECR 2025 to support equitable and sustainable access to MR
News Preview
GE HealthCare (Nasdaq: GEHC) today unveiled Freelium™,ii a next-generation sealed magnet platform, that aims to enable high-quality Magnetic Resonance (MR) imaging with less than 1% of helium used in conventional magnet technology to help support diagnostic accuracy and sustainability goals. Debuting at the European Congress of Radiology (ECR), Fr...
Themefolio
Profiler
Peergroup
© BusinessWire
25.02.2025
GEHC
LISTED
NASDAQ
Patients in the US undergo first doses of GE HealthCare’s new PET radiotracer, Flyrcado (flurpiridaz F 18) injection
News Preview
GE HealthCare (Nasdaq: GEHC) has delivered the first patient doses of Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging (PET MPI) agent for the detection of coronary artery disease (CAD), at early adopter imaging centers in the US. This milestone follows the recent FDA a...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
